Methods The Delphi Consensus Initiative presented here is focused on how to reduce the
time to diagnosis of DMD. The development process for this initiative is summarized in …

Duchenne muscular dystrophy (DMD) is the most common severe heritable muscle disorder
of childhood. Affected boys show first symptoms around the age of 2–5 years with …

Background Over the last 30 years, there has been little improvement in the age of diagnosis
of Duchenne muscular dystrophy (DMD)(mean age of 4.5–4.11 years). Aim To review the …

Duchenne muscular dystrophy is the most common form of childhood muscular dystrophy. A
mutation in the DMD gene disrupts dystrophin (protein) production, causing damage to …

Purpose Duchenne muscular dystrophy (DMD) is a rare neuromuscular disease with no
known cure. We sought to update over 30 years of research reporting on the diagnostic …

Duchenne muscular dystrophy (DMD) is a progressive, fatal neuromuscular disorder
typically diagnosed between 4 and 5 years of age. DMD currently has five FDA approved …

Objective. To address the issue of diagnostic delay in Duchenne Muscular Dystrophy (DMD)
using developmental data from a cohort of affected boys detected by newborn screening …

Despite the early onset of clinical signs suggestive of Duchenne muscular dystrophy (DMD),
a diagnosis is often not made until four years of age or older, with a diagnostic delay of up to …

OBJECTIVE: To identify key factors for the delay in diagnosis of Duchenne muscular
dystrophy (DMD) without known family history. STUDY DESIGN: The cohort comes from the …

Introduction Our objective was to identify recent CPGs for the diagnosis and management of
DMD and summarize their characteristics and reliability. Methods We conducted a scoping …